About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Tuesday, October 3rd, 2017

The QualityStocks
Daily Stock List


Indoor Harvest Corp. (INQD)

MassiveStockProfits, Orbit Stocks, OTPicks, Penny Stock General, CFN Media Group, Cannabis Financial Network News, SmallCapVoice, Fast Money Alerts, Stock Shock and Awe, and PennyPickAlerts reported previously on Indoor Harvest Corp. (INQD), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Indoor Harvest Corp. is a developer of personalized cannabis medicines. In addition, the Company is a provider of advanced cultivation technology, methods, and processes. Indoor Harvest provides the cannabis industry production platforms for Building Integrated Agriculture (BIA) production. Listed on the OTC Markets Group’s OTCQB, the Company has its corporate office in Houston, Texas.

Indoor Harvest entered into an Agreement and Plan of Merger with Alamo CBD, on August 4, 2017. The plan completes a six-month process of work, transitioning the Company into a producer of cannabis for research and pharmaceutical development. Indoor Harvest’s patent pending aeroponic methods allow for the production of chemically consistent, contaminate free cannabis, economically at scale.

At present, Indoor Harvest is a pending applicant by way of its acquisition of Alamo CBD, to produce cannabis, under the Texas Compassionate Use program. Furthermore, Indoor Harvest is preparing an application to produce cannabis under the Controlled Substance Act.

Also, the Company is finalizing plans with investors and developers to build facilities in the States of Arizona and Colorado. Indoor Harvest’s intention is to produce revenue from its developed facilities via leasing and licensing of its technology and methods.

Mr. Chad Sykes, the Company’s Founder, said this past August, “It has been an honor to lead the Company’s change management efforts. I will now be stepping aside and assuming the role as Chief of Cultivation of Alamo CBD, allowing me to focus my energy on driving cannabis cultivation science to the next level; something I’m very passionate about. I believe the team that has been assembled will prove truly disruptive to the industry. We’ve got a great team of people who are now focused on a single effort and goal, to become the leading producer of research and pharmaceutical grade cannabis.” 

As part of this transition, Mr. John Zimmerman, PE, will remain on as Vice President and Director of the Company. A committee made up of Chad Sykes, Dr. Coleman, Chief Executive Officer (CEO) of Alamo CBD, and Mr. Seckman, will work to nominate a new CEO for the Company. 

Indoor Harvest Corp. (INQD), closed Tuesday's trading session at $0.17, down 4.76%, on 30,995 volume with 5 trades. The average volume for the last 60 days is 18,335 and the stock's 52-week low/high is $0.1237/$0.90.

Bion Environmental Technologies, Inc. (BNET)

TopPennyStockMovers, SECFilings News, Wall Street Resources, OTC Stock Review, and Stock Guru reported previously on Bion Environmental Technologies, Inc. (BNET), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Bion Environmental Technologies, Inc. is a developer of advanced livestock waste treatment and resource recovery technology. The Company’s patented, next-generation technology provides verified comprehensive treatment of animal waste from large-scale livestock production facilities. Bion Environmental Technologies has its corporate office in Crestone, Colorado, and its administrative office in Old Bethpage, New York. 

The Company’s technology platform attains significant reductions in environmental impacts. This includes nutrients (nitrogen and phosphorus), ammonia, greenhouse and other gases, and pathogens in the waste stream. This is while improving resource and operational efficiencies via the recovery of valuable byproducts.

Bion’s technology platform is a modular system. It can be configured in an array of ways, depending on farm- and region-specific requirements. The system creates new revenue sources and opportunities for the producer.

The Company’s treatment solutions are a combination of biological, mechanical, as well as thermal processes. These are proven in commercial operations. They have been accepted by the EPA (Environmental Protection Agency), the USDA (United States Department of Agriculture), and other regulatory agencies.

Bion’s 2nd generation (2G) Comprehensive Environmental Management System removes up to 95 percent of the nutrients from the livestock waste effluent. It considerably decreases air emissions, including ammonia (as great as 90 percent or more), greenhouse gases, hydrogen sulfide, VOC’s and others. This system extracts renewable energy from the waste stream in the form of cellulosic biomass.

In July of this year, Bion Environmental Technologies announced that it filed a continuation of its September 2015 patent for a livestock ammonia recovery process. This process converts the ammonia into stable ammonium bicarbonate. This filing will provide broadened protection for improvements to the technology platform that will enable naturally-occurring ammonia and carbon dioxide in the waste stream to be captured, separated, distilled, recombined, and also concentrated into a solid (crystal) ammonium bicarbonate product.

Bion Environmental Technologies’ anticipation is that the ammonium bicarbonate produced in its system can be certified for use in organic production. Organic certification for the Company’s ammonium bicarbonate will result in considerably higher values than chemically-produced alternatives. Bion’s anticipation is that the leftover residual solids, which contain the remaining nitrogen, and also salts and minerals, can also undergo processing to qualify for organic use as a soil amendment product, depending on market values.

Bion Environmental Technologies, Inc. (BNET), closed Tuesday's trading session at $0.76, even for the day, on 691 volume with 3 trades. The average volume for the last 60 days is 7,243 and the stock's 52-week low/high is $0.44/$1.09.

The Pulse Beverage Corporation (PLSB)

The Green Baron, PennyStocksV2, BestStocksDaily, Wall Street Resources, RedChip, Marketbeat, Greenbackers, Microcap MarketPlace, Wall St Insider Stocks, Ceocast News, SmallCap Network, FreeRealTime, HoleinOneStocks, and PennyStockClub reported earlier on The Pulse Beverage Corporation (PLSB) and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

The Pulse Beverage Corporation is the maker of Natural Cabana® Lemonades, Limeades, and Coconut Waters. Pulse introduced Natural Cabana® Lemonade in 2012. Since that time, it has developed a multi-national distribution system through greater than 155 distributors in 49 U.S. States, Canada, Mexico, Panama, Bermuda, and Ireland.  The Pulse Beverage Corporation is based in Northglenn, Colorado. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Pulse’s goal is to be one of the market leaders in the development and marketing of nutritional/functional beverage products that provide real health benefits to a large portion of the population and are convenient and appealing to consumers. The Company offers Natural Cabana® Lemonade/Limeade in seven, low-calorie flavors. In addition, it offers Natural Cabana® Coconut Water in pineapple and natural flavors.

Pulse Beverage’s business model uses warehouse direct and key accounts. The Company has secured more than 20,000 listings for its Lemonades and Limeades and more than 5,000 listings for its Coconut Waters with regional and national grocery and convenience chain stores. 

Pulse Beverage teams up with major retailers. These retailers include Walmart, Albertsons/Safeway, Food Max, Kroger, Stater Bros, Houchens, 7-Eleven, United C-stores, Kmart, and Weis Markets. Major retailers also include King Kullen, WinCo Foods, Price Less Markets, Hy-Vee Supermarket, Gristede's Foods, Toot n Totem, and Travel America.

In September, Pulse Beverage announced that it started to ship its Natural Cabana® Coconut Waters to SunRidge Farms™ operating in Santa Cruz County, California. These products will be distributed to its Northern California Natural and Organic grocery store customers.

Additionally, in September, Pulse Beverage announced that it has been providing its Natural Cabana® Coconut Waters, Lemonades and Limeades to North American consumers by way of bulk sales to DFW Supply Company of Fort Worth, Texas. DFW operates a business to consumer (B2C) e-commerce website at www.BuyPulseDirect.com.

The Pulse Beverage Corporation (PLSB), closed Tuesday's trading session at $0.0012, up 9.09%, on 6,540,002 volume with 29 trades. The average volume for the last 60 days is 28,207,232 and the stock's 52-week low/high is $0.0011/$0.0869.

Medifocus, Inc. (MDFZF)

Street Insider, MoneyHub, OTC Markets, and MarketWatch reported on Medifocus, Inc. (MDFZF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A Biotechnology Company, Medifocus, Inc. has a portfolio of medical technologies, which use patented Focal Thermal Technology to treat conditions ranging from Prostate Diseases to Breast Cancer. The Company develops and commercializes minimally invasive treatment systems utilized in the treatment of cancerous and benign tumors, and enlarged prostates, medically known as Benign Prostatic Hyperplasia (BPH). Listed on the OTC Markets OTCQB, Medifocus is headquartered in Columbia, Maryland.

The Company’s Prolieve®Thermodilatation™ System offers symptomatic relief to men with Benign Prostatic Hyperplasia (BPH) by way of a simple, 45-minute, in-office treatment. Prolieve® is Food and Drug Administration (FDA) and Medicare approved for treating symptomatic BPH with greater than 100,000 cases performed in the United States alone, and with proven long-term safety, efficacy, as well as durability.

The Prolieve system provides treatment that combines the Company’s microwave thermotherapy capability with a proprietary balloon compression technology to heat the prostate and dilate the prostatic urethra. The purpose of the Prolieve system is to provide a relatively painless and effective alternative to drug therapy and also certain kinds of surgical procedures to treat the symptoms of BPH.

Medifocus’ Heat Activated Gene Therapy exclusively licensed from Duke University aims at using the Company’s Focal Thermal Technology to enhance selective expression of therapeutic genes injected intratumorally to optimize cancer cell killing while reducing systemic side effects.

Medifocus’ APA 1000 Breast Cancer Treatment System developed by the Massachusetts Institute of Technology (MIT) has been shown in Phase 2 clinical trials to offer considerable additional shrinkage of the sizes of breast cancer in combined ChemoThermal therapy versus Chemotherapy alone. Moreover, it was shown to be effective in lessening margin positivity when patients were treated with APA 1000 prior to lumpectomy.
Recently, Medifocus reported considerable improvement in its financial results for the fiscal year ending March 31, 2017. It attained a 16 percent improvement in Gross Margin and an 84 percent decrease in Operating Loss during the last fiscal year. The Operating Loss significantly improved from $3,216,805 for the year ending March 31, 2016, to $511,393 for the year ending March 31, 2017.

Mr. William Jow MD, Medifocus President and Chief Executive Officer said, "Now with the more efficient operations in place, we can focus on driving sales of Prolieve® through close partnerships with our independent mobile providers and distributors, both domestically and internationally. We have achieved an important milestone in expanding the Prolieve® market beyond the U.S. for the first time in Medifocus' history. The first case of Prolieve® outside of the U.S. was recently performed by a local urologist at the Hong Kong Prostate and Urology Center." 

Medifocus, Inc. (MDFZF), closed Tuesday's trading session at $0.0321, even for the day. The average volume for the last 60 days is 18,785 and the stock's 52-week low/high is $0.006/$0.0387.

KinerjaPay Corp. (KPAY)

InvestorsHub, MarketWatch, OTC Markets, TradingView, Stockhouse, Marketbeat, and Barchart reported on KinerjaPay Corp. (KPAY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

KinerjaPay Corp. concentrates on operating a digital payment and e-commerce platform. The Company, via its wholly-owned subsidiary, PT Kinerja Pay Indonesia, enables consumers to "pay, play, and buy" by way of its secure website and mobile applications. KinerjaPay’s intention is to establish the Company as a leader in Indonesia's digital economy, with a specific focus on the middle- and low-income markets. Established in 2010, KinerjaPay has its headquarters in Indonesia.

A digital payment and ecommerce platform, KinjerPay’s services are available via its mobile applications, and on its website at www.kinerjapay.com. The KinerjaPay platform provides a secure payment solution. Moreover, it provides a developing virtual marketplace where participants can buy and sell products and services.

In May 2016, KinerjaPay entered into a partnership with Bitcoin Indonesia. This makes KinerjaPay the first e-commerce portal in Indonesia authorized to accept and transact Bitcoin across its platform. This enables account holders to convert the virtual currency to Indonesian Rupiah to pay their bills, transfer money, or make purchases in the Company's ecommerce market.

KinerjaPay offers a number of in-app services, which cater cater to mobile users. These in-app services include an eWallet, social engagement, and digital entertainment related applications. The Company is also pursuing other e-commerce verticals. These include travel, fashion, gaming, and productivity applications.

KinerjaPay has also created several inventive features designed to engage users. This includes an interactive gamification component that permits users to play and earn rewards while enjoying the benefits of shopping online. The Company is also is providing users the convenience of making online payments of their utility bills, phone top-ups/data plans, insurance premiums, automobile loan instalments, and numerous other applications.

KinerjaPay announced earlier this year a partnership with PT 24 Jam Online, the parent company of UniPin, one of Indonesia's foremost gaming platforms. UniPin gives paid subscribers online and mobile access to greater than 5,000 game titles on an assortment of platforms. With this agreement, consumers can buy UniPin gaming vouchers across the KinerjaPay platform, and KinerjaPay will earn a commission on each transaction.

This past August, KinerjaPay announced plans to expand its digital ecommerce platform with the launch of KinerjaGames. It entered a long-term License Agreement with Ace Legends Pte. Ltd. (ACE). ACE is a Singapore-based game developer.

With this Agreement, in exchange for a $100,000 investment, KPAY will become the exclusive, global Game Publisher License for ACE games. Additionally, the Company will host all the games presently published by ACE on its own KinerjaGames platform.

KinerjaPay will integrate the source codes into the existing platform enabling users to enjoy more benefits, including point rewards and KCoin rewards, through participating in the games. Furthermore, KinerjaPay will provide research and development (R&D) resources to help hasten the growth of ACE's Game Development Studio.

Last month, KinerjaPay announced that it continues to realize record growth, attaining August 2017 results over double those of July 2017 and surpassing the total Q2 results. August 2017 transaction volume was roughly 200,000 versus 70,000 during the entire Q2. KinerjaPay attributes this growth to increasing consumer awareness of the KinerjaPay platform and related services.

KinerjaPay (averaging 6,442 transactions daily) recorded roughly US$923,683 in transaction revenue in August, versus 3,268, and US$387,116, respectively, for the month of July.  

KinerjaPay Corp. (KPAY), closed Tuesday's trading session at $1.15, down 4.17%, on 8,747 volume with 20 trades. The average volume for the last 60 days is 6,130 and the stock's 52-week low/high is $0.30/$3.50.


The QualityStocks
Company Corner


AppSwarm, Inc. (SWRM)

The QualityStocks Daily Newsletter would like to spotlight AppSwarm, Inc. (SWRM). Today, AppSwarm, Inc. closed trading at $0.0158, up 31.67%, on 10,018 volume with 2 trades. The stock’s average daily volume over the past 60 days is 166,544 and its 52-week low/high is $0.002/$0.04.

AppSwarm, Inc. (OTC PINK: SWRM), a technology company specializing in the accelerated development and publishing of mobile apps, is pleased to announce its partnership with "last-mile" delivery company Estorerunner, a nationally franchised on-demand delivery service for local grocery stores and pharmacies. "Last mile" pertains to the movement of people and/or goods from a transportation hub to a customer's home. The demand for web-based applications and on-demand personalized delivery is reaching unprecedented levels, positioning last-mile delivery as a vital component of modern supply chain management.

AppSwarm, Inc. (SWRM) is a technology development and incubation acceleration company that partners up with developers through joint ventures, royalty agreements, marketing partnerships, and outright purchase agreements. Focusing on the ever-growing mobile applications market, the company provides all the resources needed for engagement, retention, virality and monetization.

The global games market generated approximately $100 billion in revenues in 2016, but large global game companies have made it extremely difficult for smaller developers to achieve success in the marketplace. As a result, many great ideas aren't monetized. AppSwarm solves this problem by providing the funding and critical business expertise needed to successfully launch and market new applications.

Business applications is another area of focus for the company. Targeting small to medium sized businesses, AppSwarm will be developing and acquiring mobile application tools and platforms that increase productivity and security via data encryption, cloud storage, content management and delivery, digital payments, automation, and customer loyalty marketing solutions. Recent acquisitions made so far represent only a small example of future planned initiatives to develop and market tools for the business community.

Regardless of the target market, AppSwarm can help developers accelerate the success of their app through funding, technology and marketing expertise, as well as a unique eco system that accelerates user acquisition. The company is able to assist at any state of development with completion of concept, market analysis, business and financial management, direct sales and marketing, social game development to ensure correct product application and expedient deployment with cost efficiency.

Ron Brewer, CEO of the company, has accumulated extensive leadership in the technology sector and brings valuable knowledge gained as a Director of Southbridge Advisory Group for nearly 20 years. Ron's C-level experience includes merger & acquisition and post-acquisition turnaround in both the private and small-cap public sector. John Rabbit, director of finance, is a seasoned business veteran that has worked with Fortune 500 firms and served in CEO, COO and CFO positions for firms ranking from $5 million to $300 million in annual revenues. John was directly involved in numerous acquisitions and served in executive capacities for several multinational subsidiaries.

With a well-suited management team, multiple synergistic revenue streams, and diversified growth strategy, AppSwarm is well positioned in a steadily growing industry with countless opportunities for capitalization. Disclaimer

AppSwarm, Inc. Blog

AppSwarm, Inc. News:

AppSwarm, Inc. Announces Joint Venture with Last-Mile Delivery Firm Estorerunner

AppSwarm, Inc. is Developing Last-Mile Delivery Application Management Platform

NetworkNewsWire Releases Exclusive Audio Interview with AppSwarm, Inc. (SWRM)

Blue Moon Zinc Corp. (TSX.V: MOON) (OTC: BMOOF)

The QualityStocks Daily Newsletter would like to spotlight Blue Moon Zinc Corp. (BMOOF). Today, Blue Moon Zinc Corp. closed trading at $0.063, off by 26.06%, on 34,500 volume with 8 trades. The stock’s average daily volume over the past 60 days is 14,115 and its 52-week low/high is $0.0074/$0.087.

Blue Moon Zinc Corp. (TSXV: MOON; US OTC: BMOOF) is pleased to announce a Mineral Resource update for its 100% owned Blue Moon zinc deposit. The deposit now comprises 3.7 million tons in the Indicated Mineral Resource category grading 8.3% zinc equivalent ("ZnEq") and 4.1 million tons of Inferred Mineral Resources grading 7.8% ZnEq, both at a 4.0% ZnEq cut-off grade.

Blue Moon Zinc Corp. (TSX.V: MOON) (OTC: BMOOF), a mineral exploration company, is focused on developing its advanced-stage, wholly owned Blue Moon zinc project in central California. The project sits within Mariposa County, an area of active mines and exploration projects since it was part of the California gold rush era. Blue Moon's 525 acres of mineral rights are assigned to patented and unpatented claims accessible by a gravel road off a nearby highway with main utility lines nearby.

The Blue Moon deposit is one of many located in the Foothills Massive Sulphide Belt in the Sierra Nevada Mountains of California. The property has a long history of exploration and saw small-scale mining during World War II. The current project, to be mined by underground methods, contains an estimated 3.70 million tons with a grade of 8.33% zinc equivalent for approximately 377 million pounds of zinc in the indicated category and another 4.09 million tons with a grade of 7.84% zinc equivalence for approximately 395 pounds of zinc in the inferred category. Significant bi-products of copper, silver and gold are also indicated. The deposit is open at depth and along strike with a high likelihood of expansion.

Current spot prices for zinc is approximately $1.40 per pound, which increases the potential returns of the Blue Moon project.

The historical database shows extensive plans to put the Blue Moon project into production, including several scoping and optimization studies. Past environmental work performed, along with an historical permit and reclamation plan approved for certain underground development, highlights past local county support for the project. These historical studies and permits are expected to help fast track the project's progress as they form an excellent base for the upcoming Preliminary Economic Assessment and later feasibility study.

Among the significant historical studies conducted is a 1998 metallurgical report that shows recovery rates of 95 percent for zinc and lead, 93 percent for copper, 65 percent for silver and 70 percent for gold (http://nnw.fm/U1ckE). The report indicates that simple processing methods will produce premium concentrates with easy separation of the economic minerals.

Blue Moon CEO Patrick McGrath, who has 20 years of experience in financing and executive roles in the junior mining public sector, is joined by a management team with successful track records in leading and participating in significant mineral discoveries with development-stage mining companies. The Blue Moon team also includes a member who permitted and built the Soledad mine in southern California in 2016 and a member who re-started the Mesquite mine in southern California. Local knowledge and know-how is key. The company also plans to engage a recognized third-party engineering firm to prepare a preliminary economic assessment report, expected for release in the first quarter of 2018, to demonstrate the economic viability of the Blue Moon mineral resources. Disclaimer

Blue Moon Zinc Corp. Blog

Blue Moon Zinc Corp. News:

Blue Moon Announces Updated Mineral Resource Estimate

Blue Moon Provides Corporate Update

Savant Explorations Ltd. Changes Name to Blue Moon Zinc Corp. and Stock Symbol to "MOON"

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE). Today, Global Payout, Inc. closed trading at $0.0155, off by 8.82%, on 4,477,950 volume with 69 trades. The stock’s average daily volume over the past 60 days is 2,514,071, and its 52-week low/high is $0.0077/$0.04.

Global Payout, Inc. (OTCPink: GOHE) is pleased to announce that its majority owned subsidiary, MoneyTrac Technology, Inc. (“MTRAC”, the “Company”) has completed the execution of a joint venture partnership agreement (the “JV”) with MediaTechnics Corporation’s (OTCPink: MEDT) majority owned subsidiary, BlazeNow Inc.

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout's fully configurable "banking-in-a-box" web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today's banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout's management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and "high-risk" market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and "high-risk" enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions. Disclaimer

Global Payout, Inc. Company Blog

Global Payout, Inc. News:

Global Payout’s MoneyTrac Technology, Inc. Establishes a Revenue Sharing Joint Venture Partnership with BlazeNow Inc., an Emerging Cannabis Technology Company

NetworkNewsWire Announces Publication Discussing FinTech's Role in Disrupting Traditional Financial Services

MoneyTrac Techology, Inc. Announces Revenue Through Completion of Acquisition of Southern California-Based Periodical Brand, PotSaver

InMed Pharmaceuticals, Inc. (CSE:IN) (OTCQB:IMLFF)

The QualityStocks Daily Newsletter would like to spotlight InMed Pharmaceuticals, Inc. (IMLFF). Today, InMed Pharmaceuticals, Inc. closed trading at $0.40, off by 1.23%, on 607,301 volume with 272 trades. The stock’s average daily volume over the past 60 days is 440,964, and its 52-week low/high is $0.09/$0.72.

InMed Pharmaceuticals, Inc. (CSE: IN; OTCQB: IMLFF), a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies, today announced the filing of a provisional patent application in the United States for INM-405 and other unique compositions as cannabinoid-based topical therapies for the treatment of pain, which is an important step in protecting the company's intellectual and commercial property.

InMed Pharmaceuticals, Inc. (IMLFF) is a preclinical-stage biopharmaceutical company specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids. Utilizing its proprietary bioinformatics assessment tool, InMed aims to identify bioactive compounds found within the cannabis plant that have the potential to offer optimized therapeutic benefit while demonstrating limited adverse effects. This assessment tool, in combination with the company’s cannabinoid biosynthesis technology and drug development pipeline, serves as InMed’s fundamental value driver.

Bioinformatics is a proprietary, computer-based program designed to assist in the identification of novel cannabinoids using comprehensive algorithms to integrate data from numerous bioinformatics databases, as well as a database on the structure of currently approved pharmaceutical products and an extensive database on over 90 individual cannabinoid drugs found in cannabis. This extensive collection of data is derived from both public and propriety-based sources. Leveraging this tool, the company aims to create associations between approved pharmaceuticals and cannabinoids with similar structures in order to identify active cannabinoids that have the potential to treat specific diseases. Per InMed’s website, this type of bioinformatics assessment represents “significant promise for future drug discovery, as it integrates many data sets and builds holistic models to approach a specific disease.”

After discovering these promising active cannabinoids, InMed moves to test and confirm their activity in biological systems through in vitro and in vivo experimentation. It is at this stage of development that the company’s proprietary biosynthesis process of cannabinoid manufacturing will be most promising. InMed is currently developing a robust, high-yield biosynthesis process for manufacturing all 90+ naturally-occurring cannabinoids. By modifying the agriculture-based formula for harvesting cannabinoids, InMed aims to combine the inherent safety and known efficacy of the natural drug structure with the convenience, control and quality of 21st Century laboratory-based manufacturing processes.

The company’s pipeline currently includes two drug candidates in preclinical development, including INM-750 for the treatment of epidermolysis bullosa (EB) and INM-085 for the treatment of glaucoma. Referred to by the Dystrophic Epidermolysis Bullosa Research Association of America as “The Worst Disease You’ve Never Heard Of,” EB is a rare genetic connective tissue disorder that affects roughly one out of every 20,000 births in the United States. The condition currently has no approved treatment or cure. Through the development of INM-750, InMed is attempting to address this significant unmet medical need. The drug candidate replaces missing keratins in the skin with specially selected cannabinoids in an effort to modulate the painful manifestations of EB.

INM-085, InMed’s second development candidate, is formulated to reduce the elevated intra-ocular pressure that is often associated with glaucoma. Additionally, the cannabinoids utilized in INM-085 are expected to provide neuroprotection for the retinal ganglion cells and other optic nerve tissues following topical administration. Although it is still in preclinical development, INM-085 targets a sizable market. According to the Glaucoma Research Foundation, glaucoma is a leading cause of blindness with no approved cure. The National Institutes of Health estimates that more than 3 million Americans currently have glaucoma, and more than 120,000 have been blinded by the disease.

InMed is focused on progressing toward validation of its drug candidate selection, using data to secure its patents and developing key disruptive technologies. In 2016, the company was successful in completing financings of $1.9 million. In January 2017, InMed completed a non-brokered private placement of common shares generating aggregate gross proceeds of C$1.5 million, strongly positioning the company to attract the new investment required to fund its aggressive growth strategies in 2017.

The company’s management team has well over a century of combined experience in the biopharmaceutical space. Company CEO Eric Adams has more than 25 years of experience in company and capital formation, global market development, mergers and acquisitions, licensing and corporate governance. During his time as CEO of enGene Inc., he led the gene therapy startup to a position at the head of the industry.

Joining Adams on the InMed management team are Chief Scientific Officer Dr. Sazzan Hossain; Senior Vice President, Clinical and Regulatory Affairs Alexandra D.J. Mancini; SVP, Corporate Strategy & Investor Relations Chris Bogart; and Chief Financial Officer Jeff Charpentier, as well as Chief Medical Officer Dr. Ado Muhammed, MD, DPM, MFPM.

Muhammed, in particular, has an extensive history in the pharmaceutical industry, having previously served as an executive of GW Pharmaceuticals, a global leader in the development of cannabinoid-based medicines. During his time as Associate Medical Director of that company, Muhammed played an instrumental role in the development and FDA approval of one of the first cannabis drugs. This GW Pharmaceuticals development program coincided with a sharp rise in share price from less than $9 in 2013 to more than $129 today, with the company’s current market value totaling more than $2.9 billion. Disclaimer

InMed Pharmaceuticals, Inc. Company Blog

InMed Pharmaceuticals, Inc. News:

InMed Pharmaceuticals Files Provisional Patent for Pain Program

NetworkNewsWire Announces Publication Highlighting Companies Engaged in Advanced Cannabinoid Research

NetworkNewsWire Announces Publication Highlighting Unique Technology in Cannabinoid-Based Medicine

Patriot One Technologies, Inc. (TSX.V:PAT) (OTCQB:PTOTF)

The QualityStocks Daily Newsletter would like to spotlight Patriot One Technologies, Inc. (PTOTF). Today, Patriot One Technologies, Inc. closed trading at $1.0567, up 60.11%, on 1,085,597 volume with 545 trades. The stock’s average daily volume over the past 60 days is 58,277, and its 52-week low/high is $0.4665/$1.49.

Patriot One Technologies, Inc. (TSX.V: PAT) (OTCQB: PTOTF) is leveraging seven years of development to create powerful technologies that mitigate security risks by detecting concealed weapons via novel radar technology.

Developed through a NATO-funded project at McMaster University, Patriot One's disruptive NForce CMR1000 technology is the first cost-effective solution available for active shooter prevention, the need for which is evidenced by an increasing number of active shooter events in the United States and worldwide.

A recent study that surveyed data going back as far as 1966 demonstrates that there have been significantly more mass shootings in the U.S. than any other country for decades. Statistics for the 46-year period shows that even though America only holds 5% of the world's population, it took count of 31% of all public mass shootings. According to the FBI, there were an astounding 160 incidents from 2000 to 2013 that resulted in 486 people killed and 557 wounded. In years 2014 and 2015, there were nearly six times as many incidents compared to 2000 and 2001. The disturbing trend shows that there will be increasingly more incidents if better preventative measures aren't taken.

Patriot One's patent-pending solution to this alarming progression enables stand-off detection, even on moving targets, with a "cognitive" ability to learn and identify new threats once deployed. The product is not intended to threaten the constitutional rights of legal gun carriers, and it is also void of privacy and health concerns of traditional detection technologies, which require subject compliance, present false positives, and are often slow, inefficient and costly.

In contrast, Patriot One's technology is small in size and can be "covertly" placed in a doorway or hallway to prevent planned attacks in public places like schools, concerts, stadiums, banks, airports, offices, hospitals, shopping centers and other facilities for which there are concerns. With this method of deployment, there is no subject compliance requirement. In addition, because an image of the target is not generated, there are also no privacy concerns. Detection is real-time and entirely computer-based, which means there is no need for human operators to alert security. This eliminates the safety concerns of a would-be operator, reduces the expense of a human operator, and enables overall accuracy of 93%.

The technology is designed to identify if someone is carrying a gun, knife, suicide vest, etc., by analyzing metal content and relating it to a database of known weapon signatures. Patriot One believes the widespread use of this detection technology could act as an effective deterrent, thereby diminishing the epidemic phenomena of active shooters across the nation and around the world.

The company is guided by a team of experts in the areas of high-frequency electromagnetics, counter-terrorism, conflict resolution, government/corporate interface, sensor development, proactive security and business development. Senior Management has partnered with, among other affiliates, Ridge Global, which was founded by recently appointed advisory board member Tom Ridge, the first head of the Department of Homeland Security, first U.S. Secretary of Homeland Security, and 43rd governor of Pennsylvania.

Along with its partners, Patriot One is addressing global concerns of active shooting events and other violent terrorist attacks. The key is to short-circuit the event through effective prevention technologies and security protocols. Disclaimer

Patriot One Technologies, Inc. Company Blog

Patriot One Technologies, Inc. News:

Patriot One Receives FCC Approval for PATSCAN CMR Paving Way for Commercial Roll-Out

March Networks and Patriot One Announce Integrated Video and Covert Weapon Detection Solution

Patriot One to Present at Extraordinary Future 2017 Investment Conference


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



Small Cap Firm
(REXLQ) +900.00%


(CLSN) +301.32%


(MTBC) +109.27%

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251